Amanda L. Christie - Concepedia

Author

Amanda L. Christie

Also Known As

A L Christie, A. L. Christie, Amanda Christie, Amanda L Christie, Amanda L. Christie, Amanda L. Christie, Kristen Stevenson

117

Publications

9.1K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Imaging Center Broad Institute

About

Amanda L. Christie is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	7K
2	Cell Biology	13	13	2.4K
3	Natural Sciences	2	2	226
4	Engineering	1	1	302
5	Health Sciences	1	1	104

Amanda L. Christie

Publications

Citations

H-Index

Page 1

	Year	Citations
Selective inhibition of BET bromodomains P. Filippakopoulos, Jun Qi, S. Picaud, Nature Bet BromodomainsGeneticsPathogenesisMolecular GeneticsMedicine	2010	4.2K
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction Hiroyuki Inuzuka, Shavali Shaik, Ichiro Onoyama, Nature Signaling PathwayCell RegulationApoptosisImmunologyCellular Apoptosis	2011	628
Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma Yu‐Tzu Tai, Patrick A. Mayes, Chirag Acharya, Blood	2014	472
Mediator kinase inhibition further activates super-enhancer-associated genes in AML Henry E. Pelish, Brian B. Liau, I Niţulescu, Nature Mediator Kinase InhibitionTranscriptional RegulationSignal TransductionSignaling PathwayCell Regulation	2015	391
The Requirement for Cyclin D Function in Tumor Maintenance Yoon Jong Choi, Xiaoyu Li, Per Hydbring, Cancer Cell OncologyMedicinePathologyAnti-cancer AgentCyclin D Function	2012	345
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou, Cancer Cell Knockout MouseXenotransplantationXenografts Enables DiscoveryEngineeringIn Vivo System	2016	302
Differentiation of NUT Midline Carcinoma by Epigenomic Reprogramming Brian E. Schwartz, Matthias D. Hofer, Madeleine E. Lemieux, Cancer Research Nut Midline CarcinomaCancer ResearchOncologyOncogenic AgentMedicine	2011	216
Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells Julia Etchin, Qingxiang Sun, Alex Kentsis, Leukemia	2012	190
Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia Alex Kentsis, Casie Reed, Kim L. Rice, Nature Medicine Hematological MalignancySignal TransductionMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaReceptor Tyrosine Kinase	2012	182
<scp>KPT</scp>‐330 inhibitor of <scp>CRM</scp>1 (<scp>XPO</scp>1)‐mediated nuclear export has selective anti‐leukaemic activity in preclinical models of <scp>T</scp>‐cell acute lymphoblastic leukaemia and acute myeloid leukaemia Julia Etchin, Takaomi Sanda, Marc R. Mansour, British Journal of Haematology	2013	173

Page 1